Tavaborole Approval Status beta

Tavaborole is a topical antifungal drug in development for the treatment of onychomycosis.

FDA Approval Status for tavaborole

Oct  3, 2013Anacor Pharmaceuticals Announces FDA Acceptance of Tavaborole NDA for Filing
Jul 29, 2013Anacor Pharmaceuticals Announces That It Has Submitted a New Drug Application to the FDA for Tavaborole

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.